Assyro AI
FDA 483 Database

FDA Form 483s Issued in March 2023

Every published Form FDA 483 issued in March 2023, drawn from the FDA OII FOIA Electronic Reading Room. Each row links to the FDA source record.

18

Published 483s in March 2023

17

Distinct firms

Form 483s issued in March 2023

Regeneron Ireland Designated Activity CompanyFDA
FEI
3011684330
Issued
Mar 14, 2023
Establishment
Active Pharmaceutical Ingredient Manufacturer
Location
Ireland
TERUMO YAMAGUCHI CORPORATIONFDA
FEI
3013611763
Issued
Mar 30, 2023
Establishment
Finished Pharmaceutical Manufacturer
Location
Japan
Hugel, Inc.FDA
FEI
3012163998
Issued
Mar 10, 2023
Establishment
Active Pharmaceutical Ingredient & Finished Dosage Manufacturer
Location
Republic of Korea
Lonza AGFDA
FEI
3002930340
Issued
Mar 28, 2023
Establishment
Active Pharmaceutical Ingredient Manufacturer
Location
Switzerland
Spectrum Laboratory ProductsFDA
FEI
2246824
Issued
Mar 24, 2023
Establishment
Repacker/Relabeler
Location
United States
SNF Holdings LLCFDA
FEI
3021886842
Issued
Mar 2, 2023
Establishment
Producer of Non Sterile Drug Products
Location
Michigan, United States
Central AdmixtureFDA
FEI
3009590582
Issued
Mar 30, 2023
Establishment
Outsourcing Facility
Location
Pennsylvania, United States
Wuxi STA  Pharmaceutical Co. Ltd.FDA
FEI
3014784835
Issued
Mar 3, 2023
Establishment
Finished Pharmaceutical Manufacturer
Location
China
Fresenius KabiFDA
FEI
3013438665
Issued
Mar 6, 2023
Establishment
Outsourcing Facility
Location
Massachusetts, United States
Palisades Compounding PharmacyFDA
FEI
3008174851
Issued
Mar 15, 2023
Establishment
Producer of Non Sterile Drug Products
Location
California, United States
Maimonides Medical CenterFDA
FEI
3015468054
Issued
Mar 9, 2023
Establishment
Producer of Sterile and Non Sterile Drug Products
Location
New York, United States
Prisma HealthFDA
FEI
3015162096
Issued
Mar 3, 2023
Establishment
Outsourcing Facility
Location
South Carolina, United States
Rentschler Biopharma SEFDA
FEI
1000291122
Issued
Mar 7, 2023
Establishment
Drug Substance Intermediate Manufacturer
Location
Germany
Alvotech HfFDA
FEI
3013702557
Issued
Mar 17, 2023
Establishment
Active Pharmaceutical Ingredient & Finished Dosage Manufacturer
Location
Iceland
Lupin LimitedFDA
FEI
3007549629
Issued
Mar 29, 2023
Establishment
Finished Pharmaceutical Manufacturer
Location
India
Lupin LimitedFDA
FEI
3007549629
Issued
Mar 29, 2023
Establishment
Finished Pharmaceutical Manufacturer
Location
India
Global Pharma Healthcare Ltd.FDA
FEI
3012323885
Issued
Mar 2, 2023
Establishment
Finished Pharmaceutical Manufacturer
Location
India
Japan Food Research LaboratoriesFDA
FEI
3004579906
Issued
Mar 29, 2023
Establishment
02/24/2025
Location
Japan

Other months in 2023

Back to the FDA 483 Database